Skip Navigation
National Institute of Environmental Health SciencesNational Institutes of Health
Increase text size Decrease text size Print this page

Publications


Books

  1. Resnik D. The Price of Truth: Money and the Norms of Science. Oxford: Oxford University Press, 2007.
  2. Resnik D. Dying Declarations: Notes from a Hospice Volunteer. Binghamton, NY: Haworth Press, 2005.
  3. Resnik D. Owning the Genome: a Moral Analysis of DNA Patenting. Albany , NY: S.U.N.Y. Press, 2004.
  4. Shamoo A and Resnik A. Responsible Conduct of Research. New York: Oxford University Press, 2003.
  5. Resnik D, Steinkraus H, Langer P. Human Germ-line Gene Therapy: Scientific, Moral and Political Issues. Georgetown, TX: RG Landes, 1999.
  6. Resnik, D. The Ethics of Science: an Introduction. New York and London: Routledge, 1998. Translated into Arabic, Chinese, Turkish, and French.

Articles

  1. Resnik D. Hidden sources of private industry funding. The American journal of bioethics : AJOB 2008; 8(8):60-61. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18802869) Exit NIEHS
  2. Resnik D, Gutierrez Ford C, and Peddada S. Perceptions of ethical problems with scientific journal peer review: an exploratory study. Science and Engineering Ethics 2008; 14(3): 305-310. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18311477) Exit NIEHS
  3. Resnik DB. Opinion: three steps to ensure good science and safe research. Good Clinical Practices Journal 2007 April:13-15.
  4. Resnik D. Beyond post-marketing research and MedWatch: longitudinal studies of drug risks. Drug Design, Development and Therapy 2007; 1: 1-5. [Abstract] (http://www.doveoa.com/journals.php?pa=abstract&content_id=79) Exit NIEHS Download (http://www.doveoa.com/cr_data/files/f_DDDT-OA-2007-2352-Resnik_93.pdf)  Download Adobe ReaderExit NIEHS (76KB).
  5. Resnik D. Randomized controlled trials in environmental health research: ethical issues. Journal of Environmental Health 2008; 70(6): 28-30. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18236934) Exit NIEHS.
  6. Resnik D. Neuroethics, national security, and secrecy. American Journal of Bioethics 2007; 5: 14-15. [Abstract] (http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17497496&ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum) Exit NIEHS.
  7. Resnik D. Openness versus secrecy in scientific research. Episteme 2006; 3: 135-147. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=) Exit NIEHS.
  8. Resnik D. Embryonic stem cell patents and human dignity. Health care analysis : HCA : Journal of Health Philosophy and Policy 2007; 3: 211-222. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17922198) Exit NIEHS.
  9. Wilson K, Schreier A, Griffin A, and Resnik D. Research records and the resolution of misconduct allegations at research universities. Accountability in Research 2006; 14: 57-71.
  10. Resnik D. Clinical trials of nanomedicine: ethical and safety issues. Research Practitioner 2006; 7: 152-59.
  11. Shamoo A and Resnik D. Ethical issues for clinical research managers. Drug Information Journal 2006; 40: 371-83.
  12. Resnik D. Openness versus Secrecy in Scientific Research. Episteme 2006; 2: 135-47. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/openness-secrecy-scientific-res.pdf)  Download Adobe Reader (104KB) .
  13. Resnik D. Compensation for research-related injuries: ethical and legal issues. Journal of Legal Medicine 2006; 27: 263-87. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/compensating-subjects.pdf)  Download Adobe Reader (140KB) .
  14. Resnik D and Vorhaus D. Genetic modification and genetic determinism. Philosophy, Ethics, and Humanities in Medicine 2006; 1: 9. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/openness-secrecy-scientific-res.pdf)  Download Adobe Reader (104KB) .
  15. Resnik D and Sharp R. Protecting third parties in human subjects research. IRB 2006; 28, 4: 1-7. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/resnik-sharp.pdf)  Download Adobe Reader (103KB) .
  16. Resnik D and Jones C. Research subjects with limited English proficiency: ethical and legal issues. Accountability in Research 2006; 13: 157-77. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/lepresearch-subjects-oct82005.pdf)  Download Adobe Reader (105KB) .
  17. Shamoo A and Resnik D. Strategies to minimize risks and exploitation in Phase One trials on healthy subjects. American Journal of Bioethics 2006; 6, 3: W1-13. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/shamoo-resnik.pdf)  Download Adobe Reader (110KB) .
  18. Resnik D, Shamoo A, and Krimsky S. Fraudulent human embryonic stem cell research in South Korea: lesson learned. Accountability in Research 2006; 13: 101-109.
  19. Resnik D. Ethics of Science. In: D Borchert (ed.). Encyclopedia of Philosophy, 2nd ed. Detroit: MacMillan Reference.
  20. Resnik D. Access to affordable medication in the developing world: social responsibility vs. profit. In: van Niekerk A and Kopelman L (eds.), Ethics and AIDS in Africa, South Africa: New Africa Books, 2005. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/drug-development-dec2004.pdf)  Download Adobe Reader (95KB) .
  21. Schreier A, Wilson K and Resnik D. Academic research record-keeping: best practices for individuals, group leaders, and institutions. Academic Medicine 2006; 81: 42-47.
  22. Resnik D. Biomedical research litigation: cases, concepts, and caveats (part I). Research Practitioner 2005; 6, 6: 212-222.
  23. Resnik D. Using electronic discussion boards to teach responsible conduct of research. Science and Engineering Ethics 2005; 11: 617-30.
  24. Resnik D. The patient’s duty to adhere to prescribed treatment: an ethical analysis. Journal of Medicine and Philosophy 2005; 30: 167-188.
  25. Resnik D and Portier C. Pesticide testing on human subjects: weighing benefits and risks. Environmental Health Perspectives 2005; 113: 813-17. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/pesticide-testing-benefit-risks.pdf)  Download Adobe Reader (93KB) .
  26. Resnik D, Sharp R, and Zeldin D. Research on environmental health interventions: ethical problems and solutions. Accountability in Research 2005; 12: 69-101. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/envhealreshumsubjfeb232005.pdf)  Download Adobe Reader (155KB) .
  27. Resnik D. Affirmative action in science and engineering. Science & Education 2005; 14: 75-93.
  28. Resnik D and Shamoo A. Bioterrorism and the responsible conduct of biomedical research. Drug Development Research 2005; 63: 121-33. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/resnik_ddr_63_121.pdf)  Download Adobe Reader (123KB) .
  29. Resnik D. Conflict of interest at the NIH: no easy solution. Hastings Center Report 2005; 35, 1: 18-20. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/nihcoihast-cen-rep.pdf)  Download Adobe Reader (60KB) .
  30. Resnik D. Eliminating the daily life risks standard from the definition of minimal risk. Journal of Medical Ethics 2005; 1: 35-8. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/35.pdf)  Download Adobe Reader (59KB) .
  31. Resnik D. Punishing medical experts for unethical testimony: a step in the right direction or a step too far? Journal of Philosophy, Science, and Law, Volume 4. [Available online] (http://www.psljournal.com/archives/all/punishing.cfm) Exit NIEHS. Accessed: January 3, 2005.
  32. Resnik D. The precautionary principle and medical decision making. Journal of Medicine and Philosophy 2004; 29: 281-99.
  33. Resnik D. Fair drug prices and the patent system. Health Care Analysis 2004; 12: 91-115.
  34. Resnik D. Some recent challenges to openness and freedom in scientific publication. In: Proceedings from a Frontis Workshop on Ethics In the Life Sciences, Wageningen University, 2004. [Available online] (http://library.wur.nl/frontis/ethics/toc_ethics.html) Exit NIEHS.
  35. Resnik D. The human genome: common resource but not common heritage. In: Proceedings from a Frontis Workshop on Ethics In the Life Sciences, Wageningen University, 2004. [Available online] (http://library.wur.nl/frontis/ethics/toc_ethics.html) Exit NIEHS.
  36. Resnik D. Patients we love to hate: the obese; an ethicist's analysis. In: White B and Zimbelman J (eds.). Moral Dilemmas in Community Health Care. New York: Pearson Longman, 2004: 237-39.
  37. Resnik D. Do health care professionals with HIV disease have a duty to warn their patients?: an ethicist's analysis. In: White B and Zimbelman J (eds.). Moral Dilemmas in Community Health Care. New York: Pearson Longman, 2004: 383-85.
  38. Resnik D. Research subjects in developing nations and vulnerability. American Journal of Bioethics 2004 4, 3: 63-64.
  39. Resnik D. Disclosing conflicts of interest to research subjects: an ethical and legal analysis. Accountability in Research 2004; 11: 141-59. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/disclosure.pdf)  Download Adobe Reader (103KB) .
  40. Resnik, D. The patient's duty to adhere to prescribed treatment: an ethical analysis. Journal of Medicine and Philosophy (in press).
  41. Resnik D. Liability for institutional review boards: from regulation to litigation. The Journal of Legal Medicine 2004; 25: 131-184.
  42. Resnik D. Terrorism and intellectual property rights. Virtual Mentor 2004; 6, 5. [Available online] (http://www.ama-assn.org/ama/pub/category/12276.html) Exit NIEHS.
  43. Resnik D. Coercion and the SATURN study. American Journal of Bioethics 2004; 4, 1: 38-40.
  44. Resnik D. Patents in the pharmaceutical biotechnology industry: legal and ethical issues. In: O Kayser and R Müller (eds.), Pharmaceutical Biotechnology. Weinheim: Wiley-VCH, 2004; 187-200.
  45. Resnik D. The distribution of biomedical research resources and international justice. Developing World Bioethics 2004; 4: 42-57. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/dewb_66.pdf)  Download Adobe Reader (74KB) .
  46. Resnik, D. A pluralistic account of intellectual property. The Journal of Business Ethics 2003; 46: 319-35.
  47. Resnik D. Toward a Philosophy of Patient Safety: Expanding the Systems Approach to Medical Error. In: B Youngberg and M Hatlie (eds.), The Patient Safety Handbook. Boston: Jones and Bartlett, 2003; 67-82.
  48. Resnik, D. Patents on human-animal chimeras and threats to human dignity. American Journal of Bioethics 2003; 3, 3: 35-36.
  49. Resnik D. Patents in the biotechnology industry: legal and ethical issues. In: Kayser O and Rainer H (eds.), Pharmaceutical Biotechnology: Drug Discovery and Clinical Applications. New York: John Wiley, 2004.
  50. Resnik, D. The Jesica Santillan tragedy: lessons learned. Hastings Center Report 2003; 33, 4: 15-20.
  51. Resnik, D. Exploitation in biomedical research. Theoretical Medicine and Bioethics 2003; 24, 3: 233-259.
  52. Resnik, D. Strengthening the United States' data protection laws: balancing public access and private control. Science and Engineering Ethics 2003; 9: 301-318.
  53. Resnik D. Setting biomedical research priorities in the 21st century. Virtual Mentor. July 2003. [Available online] (http://www.ama-assn.org/ama/pub/category/10571.html) Exit NIEHS.
  54. Resnik, D. From Baltimore to Bell Labs: reflections on two decades of debate about scientific misconduct. Accountability in Research 2003; 10: 123-135.
  55. Resnik, D. Genetic testing and primary care: a new ethic for a new setting. New Genetics and Society 2003; 22: 213-24.
  56. Resnik, D. Are DNA patents bad for medicine? Health Policy 2003; 65: 181-197.
  57. Resnik D. Genetic engineering, human. In: Post S (ed.) Encyclopedia of Bioethics, 3rd ed. New York: MacMillan, 2003; 959-66.
  58. Resnik, D. Is the precautionary principle unscientific? Studies in the History and Philosophy of Biology and the Biomedical Sciences 2003; 34: 329-44.
  59. Resnik, D. A biotechnology patent pool: an idea whose time has come The Journal of Philosophy, Science, and Law 2003; 3 (January). [Available online] (ttp://www.psljournal.com/archives/papers/biotechpatent.cfm) Exit NIEHS.
  60. Resnik, D. The commercialization of human stem cells: ethical and policy issues. Health Care Analysis 2002; 10: 127-154.
  61. Resnik D and De Ville K. Bioterroism and patent rights: "compulsory licensure" and the case of Cipro. American Journal of Bioethics 2002; 2, 3: 29-39.
  62. Perkin R and Resnik D. The agony of agonal respiration: is the last gasp necessary? Journal of Medical Ethics 2002; 28: 164-169.
  63. Resnik D. Discoveries, inventions, and gene patents. In: Magnus D, Caplan A, and McGee G (eds.). Who Owns Life? Amherst, NY: Prometheus Books, 2002; 135-159.
  64. Gardenier J. and Resnik D. The misuse of statistics: concepts, tools, and a research agenda. Accountability in Research 2002; 9, 2: 65-74.
  65. Resnik, D. Exploitation and clinical trails. American Journal of Bioethics 2002; 2, 2: 28-30.
  66. Resnik D. Copernicus, Darwin, and human embryos. Bulletin of Science, Technology, and Society 2002; 22, 1: 45-47.
  67. Resnik D. 2002. Objectivity of research, ethical aspects of. Encyclopedia of Social and Behavioral Sciences. Amsterdam: Elsevier Science. Vol. 16: 10789-93.
  68. Resnik, D; Rehm, M; Minard, R. Medicine's Undertreatment of pain: scientific, clinical, and cultural factors. Medicine, Health Care, and Philosophy 2001; 4: 277-288.
  69. Resnik D and Shamoo A. Conflicts of interest and the university. Accountability in Research 2002; 9: 45-64.
  70. Resnik D and Langer P. Human germline gene therapy reconsidered. Human Gene Therapy 2001; 12: 1449-1458.
  71. Shamoo E, Krimsky S, and Resnik D. Editorial. Accountability in Research 8, 4 2001; 281-82.
  72. Resnik D. The concept of disability in bioethics: theoretical and practical issues. American Journal of Bioethics 2000 1, 3: 46-48.
  73. Resnik, D. Research participation and financial inducements. American Journal of Bioethics 2001; 1, 2: 54-56.
  74. Resnik, D. Difficulties with Regulating Preconception Sex Selection. American Journal of Bioethics 2001; 1, 1: 21-23.
  75. Gardenier J and Resnik D. 2001. The misuse of statistics: concepts, tools, and a research agenda. Proceedings from the ORI Conference on Research on Research Integrity. Washington: ORI.
  76. Resnik D. The bioethics of gene therapy. Encyclopedia of Life Sciences. Nature Publishing Group, 2001. [Available online] (http://www.mrw.interscience.wiley.com/emrw/047001590X/home) Exit NIEHS.
  77. Resnik D. Physician-assisted suicide, the culture of medicine, and the undertreatment of pain. In: Kopleman L and De ville K (eds.), Physician Assisted Suicide: a Clash of Cultures. Dordrecht: Kluwer, 2001: 127-148.
  78. Resnik D and Rehm M. Pain in sickle cell anemia. Hastings Center Report 2001; 31, 3: 29-30.
  79. Resnik D. Setting biomedical research priorities: justice, science, and public participation. Kennedy Institute for Ethics Journal 2001; 11, 2: 181-205.
  80. Resnik, D. DNA patents and human dignity. Journal of Law, Medicine, and Ethics 2001; 29, 2: 153-165.
  81. Resnik, D. Financial interests and research bias. Perspectives on Science 2000; 8, 3: 255-285.
  82. Resnik D. Developing drugs for the developing world: an economic, legal, moral, and political dilemma. Developing World Bioethics 2001; 1, 1: 11-32. Reprinted in The International Library of Medicine, Ethics and Law. Aldershott, UK: Ashgate Publishing.
  83. Resnik, D. DNA patents and scientific discovery and innovation: assessing benefits and risks. Science and Engineering Ethics 2001; 7: 29-62.
  84. Resnik, D. Ethical dilemmas in communicating medical information to the public. Health Policy 2001; 55, 2: 129-49.
  85. Resnik, D. Patient access to medical information in the computer age: ethical concerns and issues. Cambridge Quarterly for Healthcare Ethics 2001; 10: 147-56.
  86. Resnik, D. Statistics, ethics, and research: an agenda for education and reform. Accountability in Research 2000; 8: 163-188.
  87. Resnik, D. Regulating the market for human eggs. Bioethics 2001; 15, 1: 1-25.
  88. Resnik, D. Pain and folk psychology: a clinical perspective (with replies to commentaries). Mind and Brain 2000; 1, 2: 193-207; 233-35.
  89. Resnik D. Privatized biomedical research, public fears, and the hazards of regulation: lessons from stem cell research. Health Care Analysis 1999; 7: 273-87. Reprinted in: G Tomossy and D Weisstub (eds.), Human Experimentation ands Research, Aldershot, UK: Ashgate Publishing, 2003).
  90. Resnik D. A pragmatic approach to the demarcation problem. Studies in the History and Philosophy of Science 2000; 31: 249-67.
  91. Resnik D, Ranelli P, Resnik S. The conflict between ethics and business in retail pharmacy: what about patient counseling? Journal of Business Ethics 2000; 28: 179-86.
  92. Resnik D. The Human Genome Diversity Project: ethical problems and solutions. Politics and the Life Sciences 1999; 18, 1: 1-9.
  93. Resnik D. Of maize and men: reproductive control and the threat to genetic diversity. Journal of Medicine and Philosophy 2000; 25, 4: 451-67.
  94. Resnik D. The moral significance of the therapy/enhancement distinction in human genetics. Cambridge Quarterly of Healthcare Ethics 2000; 9: 365-377. Reprinted in: Readings in Biomedical Ethics: a Canadian Focus (Pearson Education Canada, 2004).
  95. Resnik D. Conflicts of interest in science. Perspectives on Science 1998; 6, 4: 381-408.
  96. Resnik D. Sex bias in subject selection: a survey of articles published in American medical journals. Theoretical Medicine and Bioethics 1999; 20: 245-60.
  97. Resnik, D. The hazards of studying human genetic variation. Politics and the Life Sciences 1999, 18, 2: 338-40.
  98. Resnik D. Biological warfare and scientific responsibility. Bulletin of Science, Technology, and Society 1999; 17, 2: 113-16.
  99. Resnik D. Problemas y dilemas eticos la interaccion entre ciencia y medios de comunicacion. Quark 1998; 13: 59-77.
  100. Resnik D. The commodification of human reproductive materials. Journal of Medical Ethics 1998; 24: 388-93. Also reprinted in Easton, T. (ed.), Taking Sides: Clashing Views on Controversial Issues in Science, Technology, and Society (4th ed.). New York: McGraw-Hill, 2000. Also reprinted in Pence, G. (ed.), Powerweb: Philosophy. New York: McGraw Hill, 2000.
  101. Resnik D. Scientific rationality and epistemic goals. Protosoziologie 1999; 12: 258-89.
  102. Resnik D. The ethics of HIV research in developing nations (with replies to commentaries). Bioethics 1998; 12, 4: 285-306; 331-333.
  103. Resnik D. Industry-sponsored research: secrecy versus corporate responsibility. Business and Society Review 1998; 99, 1: 31-35.
  104. Resnik D. Medical misinformation on the web: mitigation or control? Computers and Society 1998; 28, 1: 35-37.
  105. Resnik D. Ethical problems and issues in the interaction between science and the media. In: Thomsen M (ed.), Proceedings from the Second Ethical Issues in Physics Workshop. Ypsilanti, MI: Eastern Michigan University, 1998.
  106. Resnik D. Germ-line manipulations, private industry, and secrecy. Politics and the Life Sciences 1998; 17 (1): 29-30.
  107. Resnik D. Human genetic engineering and social justice: a Rawlsian approach. Social Theory and Practice 1997; 23, 3: 427-448.
  108. Resnik D. Laws and development. Synthese 1997; 112: 37-51.
  109. Resnik D. A proposal for a new system of credit allocation in science. Science and Engineering Ethics 1997; 3: 237-243.
  110. Resnik D. Conference report: ethics in the cybersociety. Computers and Society, 1997; 27, 1: 46.
  111. Resnik D. Academic honesty. In: Reeve A (ed.), Changes, Challenges and Choices, 3rd edition. Belmont, CA: Wadsworth, 1997.
  112. Resnik D. The morality of human gene patents. Kennedy Institute for Ethics Journal 1997; 7, 1: 31-49. Also reprinted in P Tittle (ed.), Ethical Issues in Business, Orchard Park, NY: Broadview Press, pp. 455-468.
  113. Resnik D. Adaptationism: hypothesis or heuristic? Biology and Philosophy 1997; 12: 39-50.
  114. Resnik D. Social epistemology and the ethics of research. Studies in the History and Philosophy of Science 1996; 27: 566-586.
  115. Resnik D. Basic research and corporate responsibility. Business and Society Review 1996; 96: 57-59.
  116. Resnik D. Data falsification in clinical trials. Science Communication 1996; 18, 1: 49-58.
  117. Resnik D. The ethics of cyber relationships. Computers and Society, 1996; 26, 1: 16-19.
  118. Thomsen M and Resnik D. The effectiveness of erratum in reducing error propagation in physics. Science and Engineering Ethics 1995; 1: 231-240.
  119. Resnik D. To test or not to test: a clinical dilemma. Theoretical Medicine 1995; 16: 141-52.
  120. Resnik D. Developmental constraints and patterns: some pertinent distinctions. Journal of Theoretical Biology 1995; 173: 231-240.
  121. Resnik D. Functional language and biological discovery. Journal for General Philosophy of Science 1995; 26: 119-34.
  122. Resnik D. Methodological conservatism and social epistemology. International Studies in the Philosophy of Science 1994; 8: 247-64.
  123. Resnik D. Philosophical foundations for an ethics for science. In Thomsen M (ed. ), Proceedings from the workshop on ethical issues in physics. Ypsilanti, MI: Eastern Michigan University, 1994.
  124. Resnik D. Epistemic value: truth or explanation? Metaphilosophy 1994; 25: 348-61.
  125. Resnik D. Hacking's experimental realism. Canadian Journal of Philosophy 1994; 24: 395-412. Also reprinted in Curd M and Clover J (eds.), Philosophy of Science: The Central Issues. New York: WW Norton, 1998.
  126. Resnik D. Repairing the reticulated model of scientific rationality. Erkenntnis 1994; 40: 343-55.
  127. Resnik D. The rebirth of rational morphology: process structuralism's philosophy of biology. Acta Biotheoretica 1994; 42: 1-14.
  128. Resnik D. Debunking the slippery slope argument against human germ-line gene therapy. Journal of Medicine and Philosophy 1993; 19: 23-40. Reprinted in: P Tittle (ed.), Should Parents Be Licensed? New York: Prometheus Books: 176-89.
  129. Resnik D. Do scientific aims justify methodological rules? Erkenntnis 1993; 38: 223-232.
  130. Resnik D. Genetic privacy in employment. Public Affairs Quarterly 1993; 7: 47-56.
  131. Resnik D. Convergent realism and approximate truth. Proceedings from the Philosophy of Science Association, 1992; 1: 421-34.
  132. Resnik D. Are methodological rules hypothetical imperatives? Philosophy of Science 1992; 59: 498-507.
  133. Resnik D. Gaia: from fringe science to research program. Perspectives in Biology and Medicine 1992; 35: 572-82.
  134. Resnik D. The fittingness theory of truth. Philosophical Studies 1992; 68: 95-101.
  135. Resnik D. How-possibly explanations in biology. Acta Biotheoretica 1991; 39: 141-49.
  136. Resnik D. Simplicity in evolutionary explanations. In Rescher N (ed.), Aesthetic Factors in Natural Science. Pittsburgh: University Press of America, 1990.
  137. Resnik D. Sociobiology and Panglossianism. Biology and Philosophy 1989; 4: 182-185.
  138. Resnik D and Resnik S. What's a pharmacist to do? Hastings Center Report 1989; 19, 3: 38-39.
  139. Resnik D. Adaptationist explanations. Studies in the History and Philosophy of Science 1989; 20, 2: 193-213.
  140. Resnik D. Survival of the fittest: law of probability or law of evolution? Biology and Philosophy 1988; 3: 349-362.
  141. Resnik D. Research ethics consultation at the National Institute of Environmental Health Sciences. American Journal of Bioethics 2008; 8(3):40-42. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18570102) Exit NIEHS

Back to top Back to top

Abstracts

  1. Resnik D. Bioethics and global climate change. Bioethics Forum 2007 (-). [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=) Exit NIEHS
  2. Resnik D. Health, justice, and the environment. Proceedings from the 2005 American Society for Bioethics and Humanities Annual Meetings. Glenview, IL: ASBH, 2005.
  3. Resnik D. Using Electronic Discussion Boards to Teach Responsible Conduct of Research. Proceedings from the 2004 ORI Conference on Research on Research Integrity. Potomac, MD: ORI, 2004.
  4. Wilson K, Schreier A, and Resnik D. Scientific Recording Keeping and the Responsible Conduct of Research. Proceedings from the 2004 ORI Conference on Research on Research Integrity. Potomac, MD: ORI, 2004.
  5. Resnik D. Normative Models of Data Management. Proceedings from the 2002 ORI Conference on Research Integrity. Potomac, MD: ORI, 2002.
  6. Resnik, D. Statistics and Ethics: an Agenda for Education and Reform. Proceedings from the ORI Conference on Research on Research Ethics. Bethesda, MD: ORI, 2000.
  7. Resnik, D. Ethical and Social Issues in Human Germline Gene Therapy: A Retrospective View from 1990-2000, Proceedings from the ELSI 10th Anniversary Conference. Bethesda, MD: ELSI, 2001.
  8. Resnik, D. Ethical issues in data representation. Proceedings from the 166th National Meeting of the American Association for the Advancement of Science. Washington, DC: American Association for the Advancement of Science, 2000.
  9. Resnik D. Conflicts of interest in science. Proceedings from the 165th National Meeting of the American Association for the Advancement of Science. Washington, DC: American Association for the Advancement of Science, 1999.
  10. Resnik D. Using the case method in teaching ethics in research. Proceedings from the 163rd National Meeting of the American Association for the Advancement of Science. Washington, DC: American Association for the Advancement of Science, 1997.
  11. Resnik D. Research ethics consultation at the National Institute of Environmental Health Sciences. The American journal of bioethics : AJOB 2008 8(3):40-42. [Abstract] (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18570102) Exit NIEHS

Back to top Back to top

Download Articles

  1. Resnik D. Compensation for research-related injuries: ethical and legal issues. Journal of Legal Medicine 2006; 27: 263-87. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/compensating-subjects.pdf)  Download Adobe Reader (140KB) .
  2. Resnik D. Openness versus Secrecy in Scientific Research. Episteme 2006; 2: 135-47. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/openness-secrecy-scientific-res.pdf)  Download Adobe Reader (84KB) (http://www.niehs.nih.gov/research/resources/bioethics/docs/openness-secrecy-scientific-res.pdf).
  3. Resnik D. Letter to the Editor -- Protection of human subjects and scientific progress: Can the two be reconciled? Hastings Center Report Jan-Feb 2006. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/letters.pdf)  Download Adobe Reader (80KB) .
  4. Resnik D. Letter to the Editor -- The need for international stem cell agreements. Nature Biotechnology 2006; 22(10): 1207 Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/resnik.pdf)  Download Adobe Reader (104KB) .
  5. Resnik D and Jones C. Research subjects with limited English proficiency: ethical and legal issues. Accountability in Research 2006; 13: 157-77. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/lepresearch-subjects-oct82005.pdf)  Download Adobe Reader (105KB) .
  6. Resnik D and Sharp R. Protecting third parties in human subjects research. IRB 2006; 28(4): 1-7. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/resnik-sharp.pdf)  Download Adobe Reader (103KB) .
  7. Resnik D and Vorhaus D. Genetic modification and genetic determinism. Philosophy, Ethics, and Humanities in Medicine 2006; 1: 9. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/gmgd-june182006.pdf)  Download Adobe Reader (114KB) .
  8. Shamoo A and Resnik D. Strategies to minimize risks and exploitation in Phase One trials on healthy subjects. American Journal of Bioethics 2006; 6(3): W1-13. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/shamoo-resnik.pdf)  Download Adobe Reader (110KB) .
  9. Resnik D. Access to affordable medication in the developing world: social responsibility vs. profit. In: van Niekerk A and Kopelman L (eds.), Ethics and AIDS in Africa, South Africa: New Africa Books, 2005. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/drug-development-dec2004.pdf)  Download Adobe Reader (95KB) .
  10. Resnik D. Conflict of interest at the NIH: no easy solution. Hastings Center Report 2005; 35, 1: 18-20. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/nihcoihast-cen-rep.pdf)  Download Adobe Reader (60KB) .
  11. Resnik D. Eliminating the daily life risks standard from the definition of minimal risk. Journal of Medical Ethics 2005; 1:35-8. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/35.pdf)  Download Adobe Reader (59KB) .
  12. Resnik D and Portier C. Pesticide testing on human subjects: weighing benefits and risks. Environmental Health Perspectives 2005; 113: 813-17. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/pesticide-testing-benefit-risks.pdf)  Download Adobe Reader (109KB) .
  13. Resnik D and Shamoo A. Bioterrorism and the responsible conduct of biomedical research. Drug Development Research 2005; 63: 121-33. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/resnik_ddr_63_121.pdf)  Download Adobe Reader (123KB) .
  14. Resnik D. Disclosing conflicts of interest to research subjects: an ethical and legal analysis. Accountability in Research 2004; 11: 141-59. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/disclosure.pdf)  Download Adobe Reader (103KB) .
  15. Resnik D. The distribution of biomedical research resources and international justice. Developing World Bioethics 2004; 4: 42-57. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/dewb_66.pdf)  Download Adobe Reader (74KB) .
  16. Resnik D, Sharp R, and Zeldin D. Research on environmental health interventions: ethical problems and solutions. Accountability in Research 2005; 12: 69-101. Download (http://www.niehs.nih.gov/research/resources/bioethics/docs/envhealreshumsubjfeb232005.pdf)  Download Adobe Reader (155KB) .

Back to top Back to top

USA.gov Department of Health & Human Services National Institutes of Health
This page URL: http://www.niehs.nih.gov/research/resources/bioethics/publications.cfm
NIEHS website: http://www.niehs.nih.gov/
Email the Web Manager at webmanager@niehs.nih.gov
Last Reviewed: December 09, 2008